Novacyt S.A. (CDI) (NCYT)

Sector:

Health Care

Index:

FTSE AIM All-Share

33.25p
   
  • Change Today:
      0.45p
  • 52 Week High: 49.00
  • 52 Week Low: 31.00
  • Currency: UK Pounds
  • Shares Issued: 72.59m
  • Volume: 17,992
  • Market Cap: £24.14m
  • RiskGrade: 453
  • Beta: 0.02

NCYT Overview

The Novacyt Group is a rapidly growing, international diagnostics group with a growing portfolio of cancer and infectious disease products and services. Through its proprietary technology platform, NOVAPrep®, and molecular platform, genesig®, Novacyt is able to provide an extensive range of oncology and infectious disease diagnostic products across an extensive international distributor network. The Group has diversified sales from diagnostic reagents used in oncology, microbiology, haematology and serology markets, and its global customers and partners include major corporates.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -190.2% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 1.3 n/a
Pr/Book 0.5  
Latest F'cast
Revenue 84.8% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

NCYT Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 277.20 165.17 194.00p 4.4 n/a n/a n/a 0.0%
31-Dec-21 92.60 (5.66) (9.00)p n/a n/a n/a n/a 0.0%
31-Dec-22 21.04 (20.05) (31.00)p n/a n/a n/a n/a 0.0%
31-Dec-23 10.62 (24.46) (34.00)p n/a n/a n/a n/a 0.0%
31-Dec-24 19.63 (39.43) (55.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Latest NCYT Director Deals

Traded Action Notifier PriceAmountValue
27-Mar-26 Buy Ian David Gilham 34.42p 28,750 £9,894.31
27-Mar-26 Buy John Brown 38.99p 73,762 £28,759.80
26-Mar-26 Buy Lyn Rees 33.73p 73,379 £24,751.21

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

NCYT Market Data

Currency UK Pounds
Share Price 33.25p
Change Today 0.45p
% Change 1.37 %
52 Week High 49.00
52 Week Low 31.00
Volume 17,992
Shares Issued 72.59m
Market Cap £24.14m
Beta 0.02
RiskGrade 453

NCYT Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
68.66% above the market average68.66% above the market average68.66% above the market average68.66% above the market average68.66% above the market average
69.70% above the sector average69.70% above the sector average69.70% above the sector average69.70% above the sector average69.70% above the sector average
Price Trend
74.89% below the market average74.89% below the market average74.89% below the market average74.89% below the market average74.89% below the market average
25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average
Income Not Available
Growth
11.25% above the market average11.25% above the market average11.25% above the market average11.25% above the market average11.25% above the market average
2.86% below the sector average2.86% below the sector average2.86% below the sector average2.86% below the sector average2.86% below the sector average

NCYT Dividends

No dividends found

Trades for 02-Apr-2026

Time Volume / Share Price
16:18 375 @ 32.60p
16:11 0 @ 32.60p
16:11 4 @ 33.90p
15:16 2,084 @ 33.69p
14:18 304 @ 32.60p

NCYT Key Personnel

CFO Steve Gibson

Top of Page